Form 8-K - Current report:
SEC Accession No. 0001193125-24-079597
Filing Date
2024-03-28
Accepted
2024-03-28 07:05:30
Documents
14
Period of Report
2024-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d803546d8k.htm   iXBRL 8-K 25818
2 EX-99.1 d803546dex991.htm EX-99.1 108130
  Complete submission text file 0001193125-24-079597.txt   278512

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20240328.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20240328_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20240328_pre.xml EX-101.PRE 11700
17 EXTRACTED XBRL INSTANCE DOCUMENT d803546d8k_htm.xml XML 3756
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 24793458
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)